Oral squamous cell carcinoma (OSCC) is the most common cancer of head and neck. A significant proportion of OSCC develop from premalignant lesions. The gold standard of assessing pathological changes in tissue is currently histopathology. In recent decades molecular method of disease diagnosis has gained importance as a rapid and simple method for obtaining DNA samples. Recent advances in the field of biologic science have sparked new interest in the areas of identifying cancer biomarkers in the bodily fluids. This paper reviews with advances in the techniques used for diagnosis of oral premalignant and malignant lesions.
INTRODUCTION
Oral cancer is the sixth most common malignancy worldwide. Over 300,000 new cases are reported annually. 1 Two-third cases occur in the developing countries with only 5 years survival rate. India has the highest rate of oral cancer in the world. Over 92,000 cases of oral cancer are diagnosed every year. 2 At the time of diagnosis most lesions are at stage 3. After every 7 minutes at least 1 death occurs in India due to oral cancer. 3 WHO predicts continuing increase worldwide. With earlier detection, treatment is less complicated, the cosmetic and functional results are better and survival improved. 4 
DIAGNOSTIC ADJUNCTS Cytological Techniques
Dr George Papanicolaou is known as the father of cytology and the technique is called as PAP smear. Individual cells can often be diagnosed, as such microscopically by their large size, their pleomorphism, increased nucleocytoplasmic ratio, hyperchromatism and prominence of nuclei and their abnormal mitoses. Hundred percent accuracy is seen in lymph node aspiration from metastatic carcinoma, melanoma, Hodgkin's and non-Hodgkin's
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lymphoma. Oral cytology can give false-negative findings due to inadequate sampling.
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Cyto Brush Technology
Leukoplakia, erythroplakia, chronic ulcerations, mucosa that is atrophic and common innocuous looking abnormalities can be checked for dysplastic cells. 
Vital Tissue Staining
The use of toluidine blue (tolonium chloride) are used as an aid to the diagnosis of oral cancer and potentially malignant lesions as it will stain the abnormal (reactive and dysplastic) epithelium. Whereas lugol's iodine will bind to glycogen present in normal epithelium, so is retained in normal squamous epithelial cells but not in dysplastic or malignant cells of the squamous epithelium.
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Tissue Fluorescene
In fluorescence spectroscopy (FS) cells interact with light they become excited and re-emit light of varying color (fluorescence) which is detected by sensitive spectrometer. All tissues fluorescene due to the presence of fluorophores. fluorophores are: NADH, collagen, elastin, cofactors such as flavins (FAD, FMN) . Characteristic spectra reflect the biochemical change within the tissue. Dysplastic and malignant tissues shows increased red fluorescence and decreased green fluorescence. Whereas normal tissue has increased green fluorescence. 4 Raman spectroscopy (RS) refers to a form of inelastic scattering. It is based on the shift in the frequency of incident excitation light and the vibrational frequencies of biomolecules. Four principle components in biological tissue which is responsible for resultant spectra of excited light are: water, lipids (cell membrane), nucleic acids (DNA and RNA) and proteins (hormones, isoenzymes, immunoglobulins and keratins). This technique is extremely sensitive and most accurate. Limitations are that it is expensive, complex and difficult to adapt for in vivo use. 7 Elastic scattering spectroscopy (ESS), the scattered rays occur at different gradients or wavelength resulting due to the differences in densities that occur at cellular or subcellular level. Scattering centers are nucleus, chromatic concentration and subcellular organelles. ESS is sensitive to nuclear size, chromatic content, nuclear/cytoplasmic ratio and cellular crowding. It is fast, reliable, noninvasive, cost effective and diagnosis in situ can be easily done. 4 The product designed for this technique in the market are: VEL (visually enhanced lesion scope) scope and Microlux DL. The device is used in suspicious tissue using autofluorescence under diascopic pressure, i.e. applying a light amount of pressure in a sweeping motion with the back side of the explorer (or similar instrument) to diffuse any superficial blood from the area. If the green fluorescence returns with this pressure then the lesion may be of an inflammatory nature and inappropriate care to remove the possible cause may be recommended. The examination takes only 1 or 2 minutes and is a painless, noninvasive procedure. While camera adapter allows for photo documentation and tracking of the lesion. Limitations are that some benign conditions such as physiological pigmentation, amalgam tattoos, trauma, etc. may also appear as dark regions similar to malignancy. 
Chemiluminesence
The product designed for this technique includes Vizilite plus or Vizilite with TBlue marking system. The patented single use vizilite test kit allows health care providers to improve early detection, evaluate and monitor oral mucosal abnormalities in those individuals at increased risk for oral cancer in a combination with a conventional oral mucosal examination. The disposable kit contains 54 mm plastic tube when flexed activates a nontoxic chemical light source. The activated vizilite inserted into its retractor, a 6-inched windowed hard plastic holder. Vizilite produces a diffuse light for approximately 10 minutes long enough to do a thorough visual oral examination. The kit also includes a small bottle of 1% acetic acid solution is used prior to the procedure to disrupt the glycoprotein barrier of mucosal surfaces. Vizilite passes over oral tissue that has been treated with rinse solution. Normal healthy tissue will absorb the light and appear dark, abnormal tissue will appear white.
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MICROENDOSCOPY
Andreas first used endoscope for use in the upper aerodigestive tract. The microendoscope has fitted rotating screw which allows magnification to be changed from 0× to 150×. Gives enough magnification of up to 300 times to 1,000 times. The methodology for microendoscopy is same as direct oral microscopy. 0.1% methylene blue is used as vital staining agent. The tip of microscope is applied to the prestained area of interest for assessment of underlying mucosal vasculature and blood flow. 
Direct Oral Microscopy
Helps in selecting more representative site for biopsy. It uses a specialized mobile microscope with magnification of 0×, 12× and 20×. Then lens with a green filter is used to examine the vascular changes and color tissue. 1% acetic acid is applied to the lesion for 5 seconds and dried with low-pressure airflow. 4 
DIAGNOSTIC METHODS
Biopsy
The goal of excision biopsy is to obtain the entire abnormality for histopathological examination and to provide definitive treatment by the total removal of the lesion. It is reserved for clinically benign and precancerous mucosal lesions that are less than 2 cm in diameter. For lesions greater than 3 cm in diameter, the use of multiple incisional biopsies and vital staining may be warranted to help indentify or exclude focal carcinomatous transformation. Punch biopsy can be considered for deep biopsies in the areas like palate can be relatively simple to obtain.
Early Detection of Precancerous and Cancerous Lesions: An Overview
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Imaging
Imaging options include panoramic radiography, CT, MRI and positron emission tomography. Plain film radiograph may only demonstrate gross bony involvement. Computed tomography with intravenous contrast are the most common imaging modality used in the assessment of deep tissue extension of tumors of oral cavity. It clearly demonstrate bone changes and tumor invasion and is more sensitive than MRI for lymphadenopathy. Magnetic reasonance imaging is superior in providing soft tissue details. Has multiplanar imaging capability which can better demonstrate intracranial extension of the tumor. Limitations are that bony details are not clear and cannot to be used in patients who cannot easily lie still or are claustrophobic. Ultrasound helps in evaluation of neck nodes along with the size and is a useful guide in performing FNAC for obtaining cytology. However, bone involvement cannot be evaluated as bone does not transmit sound. 1 Positron emission tomography (PET) is a form of nuclear medicine study and is used to identify nodal metastasis and recurrent tumor. PET is based on positron generation from a positron heavy nucleus. Fluorodeoxy-glucose is an imaging isotope used in PET using the difference in metabolism of radiolabeled glucose molecules between normal and malignant tissues. PET is proving to be even more specific and sensitive than CT and MRI in detection of recurrent tumors and distinguishing tumors from post radiation therapy effects. 
Sentinel Node Biopsy (SNB)
This procedure is intended to identify micrometastatic disease within a 'sentinel' node considered most likely to drain the tumor bed and receive initial metastatic deposits from the primary malignancy. Represents a less invasive means of providing staging information for the patients with oral cancer with an N0 neck. 
Molecular Methods
Recent advances in molecular studies show that an alteration at DNA level precedes microscopic morphologic changes in precancer and cancer. Evaluation of these markers may help in early characterization of oral epithelial dysplasia and squamous cell carcinoma.
NUCLEOLAR ORGANIZING REGIONS
These are loops of ribosomal DNA located on the short arms of chromosome 13, 14, 15, 21 and 22 and are associated with acidic nonhistonic proteins that can be visualized by silver staining techniques. Number and size of AgNORs correlates positively with cellular proliferation. Mean AgNOR counts differ significantly between nondysplastic and dysplastic clinical leukoplakia. With a sensitivity of 75% and specificity of 83% with a cut off mean AgNOR value of 2.37. Limitation with the technique include the time and effort required to perform the study manually as well as staining variability and counting subjectivity. 
Epigenetic Alteration, Loss of Heterozygosity (LOH) and Microsatellite Instability
The applicability of other molecular markers, such as epigenetic alterations (hypermethylation of promoter regions) and genomic instability, such as loss of heterozygosity and microsatellite instability (MSI). Rosas et al studied the methylation patterns of p16, MGMT and DAP-K genes in smears of patients suffering from head and neck cancer. They detected abnormal hypermethylation patterns in both kinds of samples by a methylation specific polymerase chain reaction (PCR). 10 Huang et al used PCR techniques to amplify DNA from exfoliated cytology samples from oral carcinomas for analysis of restriction-fragment length polymorphisms (RFLPs). They found that 66% of the tumors studied showed LOH at one position in the p53 sequence, while 55% showed LOH at some other location. Microsatellite regions are distributed along the genome and have been widely and satisfactorily used as molecular markers for carcinogenesis. 
Immunohistochemical Identification of Tumor Markers
The identification of tumor markers, notably cytokeratins in smears from the oral cavity has attracted considerable interest. Cytokeratin expression profile provides useful information on cell differentiation status but its potential for early diagnosis of oral cancer is limited. However, certain cytokeratins, such as K8 and K19 are useful if not definitive indications for malignancy, particularly if their presence is interpreted in conjunction with other information such as DNA profile.
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The Future
It has also been shown that tumor markers can be detected in the serum and more recently the saliva of patients with cancer. Seven salivary mRNA's are proposed as candidate cancer related biomarkers including interleukin (IL)-8, IL-1B, DUSP 1, HA 3, OAZ 1, SIDOP and SAT. Serum analysis by mass spectrometry was recently used to evaluate oral squamous cell carcinoma patients.
13
CONCLUSION
Technology is poised to play an active role in the diagnosis of patients with precancerous and cancerous lesions. The advanced techniques are right now used at a handful of research centers. Until more laboratories acquire needed molecular technologies, routine histopathologic examination is likely to remain the standard for detection of most patients with oral cancer.
